Observational × Head and Neck Neoplasms × Gynecologic × Clear all DP-04
Recruiting
100 enrolled
CAMPERR
Recruiting
7,000 enrolled
SCORE
Recruiting
9,600 enrolled
ELEPHAS-05
Recruiting
2,000 enrolled
ELEPHAS-02
Recruiting
416 enrolled
LIBERATE
Recruiting
2,500 enrolled
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
Active not recruiting
1,150 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
OvAR-Y
Recruiting
10 enrolled
HOPE
Not yet recruiting
80 enrolled
DESCENT-1
Enrolling by invitation
400 enrolled
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
Genomic Testing and Resulting Medical Decisions
Completed
1,500 enrolled
A Multicenter Cancer Biospecimen Collection Study
Recruiting
1,650 enrolled
PREFER
Completed
1,429 enrolled
MOHCCN-O
Recruiting
500 enrolled
Optimization of MRI for Radiation Therapy
Completed
250 enrolled
ROOT
Completed
167 enrolled
ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical, Head and Neck and Prostate Cancer
Recruiting
990 enrolled
ISRAR
Recruiting
600 enrolled
MORRIS
Completed
118 enrolled
ART-02
Recruiting
649 enrolled
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
Terminated
20 enrolled
WiZen
Completed
670,000 enrolled
DETECT
Completed
458 enrolled
PIONEER
Unknown
1,000 enrolled
Study to Evaluate the Safety of Nanoxel M Inj.
Unknown
1,498 enrolled
N1
Terminated
23 enrolled
Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy
Completed
469 enrolled
Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel
Completed
2 enrolled
Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor
Terminated
8 enrolled